Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China At Ground Zero In Explosion of New Diabetes Cases; International Federation Now Projects 500 Million Diabetics Worldwide By 2030

This article was originally published in PharmAsia News

Executive Summary

BEIJING - A vast new study conducted by scientists in North America and Asia places China at ground zero in terms of an explosion in the incidence of diabetes, and "shows that the global burden of diabetes is far larger than previously estimated," according to a scholar at the Brussels, Belgium-based International Diabetes Federation
Advertisement

Related Content

China Ramps Up Diagnostics Efforts To Deal With Diabetes Surge; Mandates Screening For At-risk Populations
Lifestyle Disease Trend Continues In Asia - WHO Epidemiology Report
Lifestyle Disease Trend Continues In Asia - WHO Epidemiology Report
Chinese Health Authorities, Alarmed By Prospect Of 100 Million-plus Diabetics, Create Doctor Training Programs As Global Drug Outfits Step Up R&D
Lilly Shifts Gears In China With New Shanghai-based R&D Center
Beijing Firm Launches Clinical Trial On Stem Cell Treatment For Diabetes
Sanofi-Aventis Asia Pacific R&D Head Frank Jiang On Opportunities In China And India: An Interview With PharmAsia News (Part 2 of 2)
Bayer Schering Partners With Polish Biotech Firm To Provide Recombinant Insulin To China's Exploding Diabetics Population
Novo Nordisk To Construct One Of World’s Largest Insulin Plants In Tianjin, China Biopharma Center
Novo Nordisk To Construct One Of World’s Largest Insulin Plants In Tianjin, China Biopharma Center
Advertisement
UsernamePublicRestriction

Register

SC074545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel